SHC News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

SH

Mkt Cap

$5.11B

Volume

999.19K

Next Earnings

November 3rd

Chart Financials Earnings News About Insider Filings

A $175 Million Move Into Sotera Health Signals Potential Opportunity Amid 21% Stock DropSessa Capital invested $175.8 million in Sotera Health by purchasing 10.6 million shares in Q4, bringing its total stake to 20.55 million shares valued at $362.5 million. Despite a 21% stock decline, the investment signals confidence in the company's fundamentals, which include $1.2 billion in revenue and steady 20-year growth, though the stock faces headwinds from litigation risks, high leverage, and a recent secondary offering that flooded the market with shares.The Motley Fool · Mar 23, 2026

Sotera Health Appoints Kenneth D. Krause to the Board of DirectorsSotera Health Company announced the appointment of Kenneth D. Krause, Executive Vice President and CFO of Rollins, Inc., as a new independent director to its Board of Directors. Krause brings over 10 years of public company CFO experience and expertise in corporate strategy and capital allocation. Simultaneously, Constantine S. Mihas resigned from the Board effective March 16, 2026, due to a reduction in stockholder-designated director positions.GlobeNewswire Inc. · Mar 16, 2026

Sotera Health Shares Rise 18% in a Year. Here's What a $37 Million Stake Trim SignalsMIG Capital sold $37.41 million worth of Sotera Health shares (2.26 million shares) in Q4 2025, reducing its stake to 5.88% of AUM. Despite the trim, the fund maintains a significant position in the sterilization and lab testing company. Sotera posted its 20th consecutive year of revenue growth with 5.7% sales increase to $1.16 billion in 2025, while net income nearly doubled to $78 million. The company projects 5-6.5% revenue growth for 2026.The Motley Fool · Mar 15, 2026

Sotera Health Announces Secondary Offering of Common StockSotera Health Company announced a secondary offering of 25 million shares of common stock being sold by affiliates of Warburg Pincus and GTCR. The company will not receive proceeds from the offering but will cover offering expenses. Wells Fargo Securities is acting as the underwriter.GlobeNewswire Inc. · Mar 4, 2026

Irenic Dumps Most Papa John's SharesIrenic Capital Management LP significantly reduced its Papa John's International position by approximately 70%, selling 748,592 shares in Q4 and retaining only 325,108 shares valued at $12.5 million. The stake now represents just 0.8% of the fund's AUM, dropping out of its top five holdings. Papa John's stock has underperformed the market, declining 30.7% over the past year while the S&P 500 gained 16.4%, amid struggling North American same-store sales.The Motley Fool · Feb 22, 2026

Sotera Health Director Warburg Pincus Sells 9.7 Million Shares for $158.7 MillionWarburg Pincus, a major shareholder and board member of Sotera Health, sold 9.7 million shares (22.18% of its indirect stake) for $158.7 million on December 3, 2025, at $16.33 per share. Despite the insider selling, Warburg Pincus retains over 34 million shares in the sterilization and lab services company, which has shown strong performance with 31.25% year-over-year growth and consistent earnings growth.The Motley Fool · Jan 8, 2026

Darsana Capital Opens New $189 Million Wingstop Position: Is the Stock a Buy?Darsana Capital initiated a new $189 million stake in Wingstop, purchasing 750,000 shares representing 4.45% of their portfolio. Despite recent same-store sales declines, the investment suggests potential long-term growth in the restaurant chain.The Motley Fool · Nov 18, 2025

Sotera Health Company Appoints Vincent K. Petrella as Lead Independent DirectorSotera Health Company, a global provider of sterilization solutions and lab services, has appointed Vincent K. Petrella as its new Lead Independent Director, effective January 2, 2025. Petrella, who has served on the company's board since 2020, brings extensive public company leadership experience and will serve as a key liaison between the board, management, and shareholders.GlobeNewswire Inc. · Jan 6, 2025

Sotera Health to Share Next Chapter of Growth at 2024 Investor DaySotera Health, a leading global provider of sterilization solutions and lab testing services, will hold an Investor Day in New York City to discuss its strategic positioning and future growth plans, including a long-term financial outlook and a 2025-2027 financial plan.GlobeNewswire Inc. · Nov 20, 2024

Pharmaceutical Sterility Testing Market to Drive Revenue to USD 3.79 Billion by 2032 | CAGR 11.58%The pharmaceutical sterility testing market is growing rapidly due to increasing demand for safe and effective pharmaceutical products, advancements in testing technologies, and the rising focus on biopharmaceuticals. The market is expected to reach $3.79 billion by 2032, driven by stringent regulations, the need for sterility testing in new therapies, and the shift towards in-house testing.GlobeNewswire Inc. · Nov 15, 2024

SH

SHCSotera Health Company Common Stock

SHC

Pay with—

Available Balance0.00

Your PositionYou don't own any SHC yet.

Related Tickers

Earnings